SG11202009855WA - Growth inhibitor - Google Patents
Growth inhibitorInfo
- Publication number
- SG11202009855WA SG11202009855WA SG11202009855WA SG11202009855WA SG11202009855WA SG 11202009855W A SG11202009855W A SG 11202009855WA SG 11202009855W A SG11202009855W A SG 11202009855WA SG 11202009855W A SG11202009855W A SG 11202009855WA SG 11202009855W A SG11202009855W A SG 11202009855WA
- Authority
- SG
- Singapore
- Prior art keywords
- growth inhibitor
- inhibitor
- growth
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/39—Pancreas; Islets of Langerhans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
- C12N5/0678—Stem cells; Progenitor cells; Precursor cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/113—Acidic fibroblast growth factor (aFGF, FGF-1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases (EC 2.)
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Developmental Biology & Embryology (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018082606 | 2018-04-23 | ||
| PCT/JP2019/017044 WO2019208505A1 (fr) | 2018-04-23 | 2019-04-22 | Inhibiteur de croissance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202009855WA true SG11202009855WA (en) | 2020-11-27 |
Family
ID=68293881
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202009855WA SG11202009855WA (en) | 2018-04-23 | 2019-04-22 | Growth inhibitor |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20210254014A1 (fr) |
| EP (1) | EP3812456A4 (fr) |
| JP (1) | JP6779509B2 (fr) |
| KR (1) | KR20210005085A (fr) |
| CN (1) | CN112313327B (fr) |
| AU (1) | AU2019261083A1 (fr) |
| BR (1) | BR112020021802A2 (fr) |
| CA (1) | CA3097962A1 (fr) |
| CO (1) | CO2020012343A2 (fr) |
| IL (1) | IL277806A (fr) |
| MX (1) | MX2020011189A (fr) |
| SG (1) | SG11202009855WA (fr) |
| TW (1) | TW201945364A (fr) |
| WO (1) | WO2019208505A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3113608A1 (fr) * | 2018-09-19 | 2020-03-26 | Takeda Pharmaceutical Company Limited | Cellules produisant de l'insuline |
| CA3208794A1 (fr) | 2021-02-09 | 2022-08-18 | Orizuru Therapeutics, Inc. | Agent de maturation |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TJ342B (en) | 1994-11-14 | 2002-10-06 | Warner Lambert Co | Derivatives of 6-aryl pyrido Ä2,3-dÜ pyrimidines and naphthyridines pharmaceutical composition possess inhibiting effect of cellular proliferation pr ovoking protein tyrosine kinase and method of inhibiting cellular proliferation |
| US6815203B1 (en) * | 1999-06-23 | 2004-11-09 | Joslin Diabetes Center, Inc. | Methods of making pancreatic islet cells |
| US8278104B2 (en) | 2005-12-13 | 2012-10-02 | Kyoto University | Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2 |
| MX2008007654A (es) | 2005-12-13 | 2008-09-26 | Univ Kyoto | Factor de reprogramacion nuclear. |
| US7661738B2 (en) | 2006-11-28 | 2010-02-16 | Veritainer Corporation | Radiation detection unit for mounting a radiation sensor to a container crane |
| AU2008231020B2 (en) | 2007-03-23 | 2013-09-05 | Wisconsin Alumni Research Foundation | Somatic cell reprogramming |
| WO2008124133A1 (fr) | 2007-04-07 | 2008-10-16 | Whitehead Institute For Biomedical Research | Reprogrammation de cellules somatiques |
| CN101802172A (zh) | 2007-05-30 | 2010-08-11 | 通用医疗公司 | 由体细胞产生多能细胞的方法 |
| JP2008307007A (ja) | 2007-06-15 | 2008-12-25 | Bayer Schering Pharma Ag | 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞 |
| EP2185695B1 (fr) | 2007-07-18 | 2015-02-25 | Lifescan, Inc. | Différenciation de cellules souches embryonnaires humaines |
| EP2305373A1 (fr) | 2008-07-24 | 2011-04-06 | Niigata University | Microcapsule, procédé pour la produire et aliment ou boisson contenant une microcapsule |
| US9446168B2 (en) | 2010-06-07 | 2016-09-20 | Beta-O2 Technologies Ltd. | Multiple-layer immune barrier for donor cells |
| US9540630B2 (en) | 2008-09-17 | 2017-01-10 | Beta O2 Technologies Ltd. | Optimization of alginate encapsulation of islets for transplantation |
| WO2012178215A1 (fr) * | 2011-06-23 | 2012-12-27 | The Children's Hospital Of Philadelphia | Lignées de progéniteurs endodermiques à auto-renouvellement générées à partir de cellules souches pluripotentes humaines et leurs procédés d'utilisation |
| CA2957000C (fr) | 2014-08-04 | 2023-08-01 | Takeda Pharmaceutical Company Limited | Procede de multiplication de cellules progenitrices pancreatiques |
| JP6885180B2 (ja) | 2016-11-08 | 2021-06-09 | 三菱電機株式会社 | モータおよびモータの製造方法 |
-
2019
- 2019-04-22 JP JP2020504253A patent/JP6779509B2/ja active Active
- 2019-04-22 WO PCT/JP2019/017044 patent/WO2019208505A1/fr unknown
- 2019-04-22 CN CN201980040636.XA patent/CN112313327B/zh active Active
- 2019-04-22 CA CA3097962A patent/CA3097962A1/fr active Pending
- 2019-04-22 BR BR112020021802-2A patent/BR112020021802A2/pt unknown
- 2019-04-22 KR KR1020207033098A patent/KR20210005085A/ko unknown
- 2019-04-22 TW TW108113987A patent/TW201945364A/zh unknown
- 2019-04-22 SG SG11202009855WA patent/SG11202009855WA/en unknown
- 2019-04-22 MX MX2020011189A patent/MX2020011189A/es unknown
- 2019-04-22 US US17/049,218 patent/US20210254014A1/en active Pending
- 2019-04-22 AU AU2019261083A patent/AU2019261083A1/en active Pending
- 2019-04-22 EP EP19793629.7A patent/EP3812456A4/fr active Pending
-
2020
- 2020-09-30 CO CONC2020/0012343A patent/CO2020012343A2/es unknown
- 2020-10-05 IL IL277806A patent/IL277806A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2020011189A (es) | 2020-11-13 |
| EP3812456A4 (fr) | 2022-01-12 |
| US20210254014A1 (en) | 2021-08-19 |
| CO2020012343A2 (es) | 2020-10-30 |
| WO2019208505A1 (fr) | 2019-10-31 |
| CA3097962A1 (fr) | 2019-10-31 |
| BR112020021802A2 (pt) | 2021-02-23 |
| IL277806A (en) | 2020-11-30 |
| CN112313327B (zh) | 2024-04-19 |
| TW201945364A (zh) | 2019-12-01 |
| JP6779509B2 (ja) | 2020-11-04 |
| CN112313327A (zh) | 2021-02-02 |
| JPWO2019208505A1 (ja) | 2020-05-28 |
| EP3812456A1 (fr) | 2021-04-28 |
| KR20210005085A (ko) | 2021-01-13 |
| AU2019261083A1 (en) | 2020-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL283639A (en) | kif18a inhibitors | |
| PT3626699T (pt) | Inibidor de ssao | |
| IL269196A (en) | New inhibitors | |
| GB201705971D0 (en) | Inhibitor compounds | |
| IL277778B (en) | inhibitors of bcl6 | |
| EP3817736A4 (fr) | Inhibiteurs de pikfyve | |
| GB201819126D0 (en) | Inhibitor compounds | |
| ZA201907136B (en) | Ip6k inhibitors | |
| IL276013A (en) | pi4kiiibeta inhibitors | |
| IL283309A (en) | rip1 inhibitors | |
| IL277806A (en) | Growth inhibitor | |
| IL281514A (en) | O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors | |
| IL274550A (en) | Dopamine-B-hydroxylase inhibitors | |
| IL283112A (en) | Lox inhibitors | |
| GB201809295D0 (en) | Lox inhibitors | |
| IL291456A (en) | Growth retarder | |
| GB201908044D0 (en) | Dopamine-B-Hydroxylase inhibitors | |
| GB201809939D0 (en) | Eastase inhibitor | |
| GB201812462D0 (en) | Inhibitors | |
| GB201905476D0 (en) | MAPA4K4 Inhibitors | |
| GB201804439D0 (en) | Dopamin-b-hydroxylase inhibitors | |
| GB201819136D0 (en) | Inhibitor compounds | |
| GB202117076D0 (en) | Nanofluids | |
| GB201905370D0 (en) | Elastate inhibition | |
| IL276108A (en) | Crystalline forms of psoorstam |